EFTA02120846Set 10
2013-11-199p2,186w
premium)
• DSM sells majority stake in pharma business to JLL Partners (will be merged with Patheon PTI CN)
• IN 9mnths external revs improve, studios solid, cost savings good, confident outlook
https://www.justice.gov/epstein/files/DataSet%2010/EFTA02120846.pdf